Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Simulations Plus, Inc.

< Previous 1 2 3 4 Next >
Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Sets Date for Second Quarter Fiscal Year 2022 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit National Organization for Rare Disorders
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Partners with Large Pharmaceutical Company to Drive Advancements to the GastroPlus Mechanistic Oral Absorption Model
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Enters New Collaboration with Leading Animal Health Company
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus to Present at Sidoti Winter Small Cap Investor Conference
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Reports First Quarter Fiscal 2022 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Lixoft Adds New Bioequivalence Module in MonolixSuite® Version 2021R1
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Sets Date for First Quarter Fiscal Year 2022 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Extends its Distributor Agreement in Japan with Northern Science Consulting for Monolix™
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit, Dispensary of Hope
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Names Sharlene Evans to Board of Directors
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Presented Breakthrough Scientific Data at Top Liver Disease Conference
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Releases RENAsym® Version 1A Software for Kidney Injury
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Releases GastroPlus® Version 9.8.2
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus and the University of Connecticut Awarded New FDA Contract to Accelerate the Development of Long-Acting Injectable Products
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Reports Fourth Quarter and Full Year Fiscal 2021 Results
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Announces the University+ Program
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Announces Cash Dividend
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2021 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Receives New Grant Award From the FDA
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Releases ADMET Predictor® (X.3)
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus to Participate in BofA Securities and Oppenheimer Investor Conferences
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Reports Continued Success in Second Phase of AIDD Collaboration with Large Pharmaceutical Company
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
NMPA’s Center for Drug Evaluation Adds Licenses of GastroPlus®
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Reports Third Quarter Fiscal 2021 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Celebrates 25 Years in Business
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantitative Systems Pharmacology (QSP) Software for Idiopathic Pulmonary Fibrosis (IPF)
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.